Gardasil HPV Vaccine Approved for Use in Adults Up to Age 45, But Will This Age Group Get the Shot?

Merck’s Gardasil 9 vaccine has now been approved for patients between the age of 27 and 45 to prevent the spread of nine types of cancer-causing human papillomavirus (HPV). However, since the HPV vaccine is most effective at preventing infection when given to boys and girls before they become sexually-active, its unclear whether this approval in older adults will have a significant effect on the number of individuals who get the shot each year.